Sponsored by:

Molecular Imaging: Page 278

IAC awards 2013 research grants
By AuntMinnie.com staff writers
The Intersocietal Accreditation Commission (IAC) has announced the grant recipients for its inaugural 2013 Research Award Program.
January 8, 2013
GE files applications for F-18 flutemetamol
By AuntMinnie.com staff writers
The U.S. Food and Drug Administration and the European Medicines Agency have accepted applications from GE Healthcare for review of its investigational F-18 flutemetamol PET amyloid imaging agent.
January 7, 2013
FluoroPharma to test PET agent at MGH
By AuntMinnie.com staff writers
Radiopharmaceutical developer FluoroPharma Medical said that a phase II trial of its F-18 tetraphenylphosphonium (TPP) BFPET agent for measuring cardiovascular blood flow will be performed at Massachusetts General Hospital (MGH).
January 3, 2013
India to build isotope facility
By AuntMinnie.com staff writers
India is building its first facility to produce medical isotopes, according to a report in the Hindustan Times.
January 2, 2013
Lantheus extends Japanese contract with Fuji
By AuntMinnie.com staff writers
Diagnostic imaging agent developer Lantheus Medical Imaging has renewed its long-term agreement with Fujifilm RI Pharma (FRI) to license and distribute the Cardiolite and Neurolite pharmaceuticals in Japan.
January 2, 2013
FDG-PET/CT aids advanced breast cancer patients
By AuntMinnie.com staff writers
FDG-PET/CT can provide "significant prognostic stratification information" at initial staging for patients with locally advanced breast cancer compared to conventional imaging, according to a study published in the January issue of the Journal of Nuclear Medicine.
January 2, 2013
Congress passes Medical Isotopes Production Act
By AuntMinnie.com staff writers
After several years of starts and stalls, the U.S. Congress last week passed the American Medical Isotopes Production Act to establish a program to support the production of molybdenum-99 for medical use in the U.S.
December 25, 2012
C-11 choline PET/MRI helps restage prostate cancer patients
By Wayne Forrest
A preliminary study by German researchers suggests that carbon-11 (C-11) choline PET/MRI may provide an alternative imaging modality to PET/CT for restaging of prostate cancer by offering equal, if not better, diagnostic performance and less radiation exposure.
December 25, 2012
AMIC plans medical isotope production in Colo.
By AuntMinnie.com staff writers
Medical isotope producer Advanced Medical Isotope (AMIC) has formed a strategic alliance with Safety by Design of Colorado to develop medical isotope products in the greater metropolitan Denver.
December 23, 2012
Contrast agent & radiopharmaceutical market decline to continue
By AuntMinnie.com staff writers
A shrinkage in the U.S. contrast agent and radiopharmaceutical market that began in 2012 is projected to continue through 2017, according to a new report from market research firm Millennium Research Group.
December 23, 2012
FDG-PET/CT shines in assessing distant cancers
By Wayne Forrest
Whole-body FDG-PET/CT offers "excellent diagnostic performance" in the assessment of distant malignancies in patients with head and neck, breast, and lung cancers, according to a new study in the Journal of Nuclear Medicine.
December 20, 2012
AuntMinnie.com Molecular Imaging Insider
By Wayne Forrest
December 19, 2012
Previous Page
Page 278 of 612
Next Page